The Neuroprotective Disease-Modifying Potential of Psychotropics in Parkinson's Disease

Neuroprotective treatments in Parkinson's disease (PD) have remained elusive. Psychotropics are commonly prescribed in PD without regard to their pathobiological effects. The authors investigated the effects of psychotropics on pathobiological proteins, proteasomal activity, mitochondrial funct...

Descripción completa

Detalles Bibliográficos
Autores principales: Lauterbach, Edward C., Fontenelle, Leonardo F., Teixeira, Antonio L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255316/
https://www.ncbi.nlm.nih.gov/pubmed/22254151
http://dx.doi.org/10.1155/2012/753548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255316/
https://www.ncbi.nlm.nih.gov/pubmed/22254151
http://dx.doi.org/10.1155/2012/753548

Ejemplares similares